LIQUISOLID TECHNIQUE FOR DISSOLUTION AND BIOAVAILABILITY ENHANCEMENT OF POORLY SOLUBLE DRUGS

Liquisolid formulations have attracted substantial interest as an efficient means of improving the dissolution and ultimately bioavailability. The technique is based upon the admixture of drug loaded solutions with appropriate carrier, coating materials and use of non-volatile solvent causes improved wettability. The inclusion complexes of drug with beta cyclodextrin (β CD) were formulated by kneading method and highest solubility complex was further used for preparation of liquisolid formulation to get synergistic effect. Also it raises drug incorporation with dissolution enhancement compared with conventional formulation. There are various techniques for bioavailability enhancement, such as altering the pharmacokinetic parameters, inhibition of enzyme etc. For this purpose some herbal inhibitors can be used; ex piperine. The prepared formulations were characterized by FTIR, DSC, PXRD and in vitro dissolution studies. Hence, this liquisolid technique with two way approach of solubility and bioavailability enhancement may found as key aspect in designing of formulations.


INTRODUCTION
It is generally recognized that poor solubility of drugs is one of the most frequently encountered difficulties in the field of formulation scheme. Low solubility and subsequent unsatisfactory dissolution rate often compromise oral bioavailability 1 . There are most therapeutic agents used to produce systemic effects by oral route that are the preferred way of administration owing to its several advantages and high patient compliance compared to other routes. However, poorly water-soluble drugs, when administered orally, have been shown to be slowly and unpredictably absorbed since their bioavailability is largely dependent on the dissolution process in gastrointestinal tract 3 . The bioavailability of many poorly water-soluble drugs is limited by their dissolution rates, which are in turn controlled by the surface area that they present for dissolution 3 . It is one of the major challenges to synthesize any new molecule, which is pharmacologically active for the researchers and pharmaceutical companies 4 . It may be necessary to increase the dose of a poorly soluble drug to obtain the efficacy required 5 . Although pharmaceuticals have been able to overcome difficulties with very slightly soluble drugs, those with aqueous solubility of less than 0.1 mg/ml present some unique challenges. These strategies include using solubilization and surfactants, the use of polymorphic/ amorphic drug forms, the reduction of drug particle size, the complexation and the formation of solid drug dispersions 6 . The Biopharmaceutical Classification System (BCS) The Biopharmaceutical classification system classifies drugs into four categories (Table 1), depending on their solubility and permeability characteristics 7 . Parameters affecting the dissolution of Class II Factors important to dissolution can be identified from the following modification of the Noyes-Whitney equation 8 :  iii. Liquid medication The term "Liquid medication" includes liquid lipophilic drugs and drug suspensions or solutions of solid water insoluble drugs in a suitable nonvolatile system. iv. Liquisolid microsystem The term "Liquisolid microsystem" refers to capsules prepared by the process described under "Liquisolid technique" combined with the inclusion of an additive, e.g. polyvinylpyrrolidone (PVP), in the liquid medication.

v. Carrier material
The term "Carrier material" refers to a preferably porous material possessing sufficient absorption properties, which contributes in liquid absorption.

vi. Coating material
The term "Coating material" refers to a material possessing fine and highly adsorptive particles, such as various types of which contribute in covering the wet carrier particles and displaying a dry looking powder by adsorbing any excess liquid.

vii. Flowable liquid retention potential (Ф-value)
The term "Flowable liquid retention potential" of a powder material describes its ability to retain a specific amount of liquid while maintaining good flow properties. The Ф-value is defined as the maximum weight of liquid that can be retained per unit weight of the powder material in order to produce an acceptably flowing liquid/powder admixture 15 . R =Q/q Excipient ratio (R) is the fraction of the weights of the carrier (Q) and coating (q) materials present in the formulation. An acceptably flowing and compressible Liquisolid system can be prepared only if a maximum liquid load on the carrier material is not exceeded. Such a characteristic amount of liquid is termed the liquid load factor (L f ) and defined as the weight ratio of the liquid medication (W) and carrier powder (Q) in the system, i.e.: L f = W/ Q The terms "acceptably flowing" and "acceptably compressible" imply preselected and desirable levels of flow and compaction which must be possessed by the final liquid: powder admixtures. Essentially, the acceptable flow and compaction characteristics of this systems are ensured in a way, built in during their manufacturing process via the Ф-value and Ψ -number concepts 16 . For powder substrate consisting of a certain carrier and coating powders mixed at various powder excipient ratios (R), there are specific maximum liquid load factors (Lf) which must be employed in order to produce acceptably flowing Liquisolid systems. Such liquid load factors based upon the Ф-value and Ψnumber can be calculated based upon following equations, 1) Based upon the Ф-value the optimum liquid load factor ( Φ L f ) can be derived by using,

Classification of Liquisolid system
Ф -Flowable retention potential for carrier material. φ -Flowable retention potential for coating material. R -Excipient ratio. 2) Similarly based upon the Ψ -number optimum liquid load ( Ψ L f ) factor can be derived from, Ψ L f = Ψ + ψ (1/R) Where, Ψ -Compressible retention potential for carrier material. ψ -Compressible retention potential for coating material. R -Excipient ratio. For a liquid medication incorporated into a given powder substrate consisting of certain carrier and coating materials (e.g. microcrystalline cellulose and silica) blended at a specific excipient ratio (R), there exists an optimum liquid load factor, L 0 , required to produce acceptably flowing and, simultaneously, acceptably compressible Liquisolid preparations. The LO value required at a given powder excipient ratio for any system is equal to either its Φ L f or Ψ L f value, whichever is less; thus: Optimum liquid load factor of a given excipient ratio system is established, the appropriate quantities of carrier (Q 0 ) and coating (q 0 ) powder materials required to convert a given amount of liquid medication (W) into an acceptably flowing and compressible Liquisolid system, may be calculated as follows: The minimum carrier quantity (Q min ) and maximum coating quantity (q max ) required to produce an acceptably flowing and compressible Liquisolid compacts unit possessing minimum weight (U min ) and containing W of liquid may assessed using following relation, Q min =W/L max q max =Q min / R min In terms of producing compacts of realistic unit size, the practical substance of the Liquisolid formulation desired to be prepared may be assessed by predicting unit dose weight U w using equation. This can be done as long as weight W of the liquid medication (to be included in a single Liquisolid formulation) and the desired excipient ratio (R) of the formulation have been selected leading to the determination of the required optimum load factor (L 0 ). The minimum possible unit dose weight (U min ) which can be produced by the carrier: coating system may also be predicted using equation, having selected the weight W of the liquid medication (per unit dose) and having determined the minimum excipient ratio (R min ) of the powder system and its corresponding maximum load factor L max required to yield a Flowable and compressible Liquisolid system 17 .

Powdered solution technology
A more recent technique, entitled "powdered solution technology", has been applied to prepare water soluble or water insoluble drugs into rapid release or sustained release solid dosage forms. The concept of powdered solutions enables one to convert drug solutions or liquid drugs into acceptably flowing powders by a simple admixture with selected powder excipients 18 .

Method of Preparation of Liquisolid system
The preparation of Liquisolid system is based on different equations.
i. Selection and preparation of drug solution: If a solid water-insoluble drug is formulated, the drug is dissolved or suspended in a non-volatile solvent or vehicle.(% w/w concentration). ii. Selection of Carrier and Coating materials: The carrier and coating materials to be incorporated in the Liquisolid formulation are selected on the basis of, the characteristic excipient or carrier: coating ratio R min (w/w) and the Flowable liquid retention potential (Ф-value) and compressible liquid retention potential (Ψ -number) are determined by using Liquisolid flowability test (LSF) and Liquisolid compressibility test (LSC) respectively. iii. The desired excipient or carrier: coating ratio R, where R>R min , of the carrier: coating combination to be included in the liquisolid system is selected. If minimum unit dose weight (U min ) is desired, the excipient ratio of the formulation must be selected to be equal to R min which is the characteristic minimum excipient ratio of the carrier: coating system used. iv. Selected amounts (W) of the resulting hot liquid medications were incorporated into calculated quantities of carrier and coating materials. v. Determination of Liquid load factor: The optimum liquid load factor (LO) required yielding an acceptable flowing and compressible Liquisolid system is assessed by using different equations 19 .

Mixing process
The mixing procedure was conducted in three stages. During the first stage, the system was blended at an approximate mixing rate of one rpm in order to consistently distribute the liquid medication into the powder. In the second stage, the liquid/powder admixture was equally spread as a uniform layer on the surface of the mortar. In the third stage, the powder was scraped off the mortar surfaces by means of an aluminum spatula, and then blended with a calculated quantity of the disintegrant or binder for another thirty seconds, producing the final liquisolid formulation to be compressed 20 .

Mechanism involved in designing of Liquisolid system
Liquisolid hypothesis that, if a liquid is incorporated into a material which has a porous surface and closely matted fibers in its interior, e.g., cellulose, both absorption and adsorption take place. The liquid is initially absorbed in the interior of the particles by its internal structure and after the saturation of process, adsorption of the liquid onto the internal and external surfaces of the porous carrier particle occurs. It represents the generalized "total liquid retention potential" or "holding capacity" of the sorbent. The coating material, which possesses high adsorptive properties and large specific surface area, gives the Liquisolid system the desirable flow characteristics 21 . Advantages of Liquisolid technique 1. A great number of slightly and very slightly water soluble and practically water insoluble drugs can be formulated in to Liquisolid system. Production cost of Liquisolid system is lower than that of soft gelatin capsule, as production of Liquisolid system is similar to that of conventional tablets 22  approach, as it is the most preferred and convenient route of administration 29 .

FORMULATION OF LIQUISOLID SYSTEM Preparation of complex with beta cyclodextrin Kneading method
Preparation of complex of drug with beta cyclodextrin done by: First the cyclodextrin is added to the mortar; further small quantity of 50% ethanol is added while triturating to get slurry like consistency. Then slowly drug is incorporated into the slurry and trituration is further continued for 30 minutes. Slurry is then air dried at 25 0 C for 1 hrs, pulverized and passed through sieve No. 80 and stored 30 .

Solubility studies of complex and synergism effect with different ratios
The complex of drug and beta cyclodextrin Complex was taken in different mass ratios, after that complex was taken in liquid vehicle for studying the synergism effect.

Determination of angle of slide for various excipients
Ten gram of powder excipients were weighed accurately and placed at one end of an aluminum metal plate with a polished surface. This end was raised gradually until the plate made an angle with the horizontal at which the powder was about to slide. This angle θ represented the angle of slide. It was taken as a measure for the flow characters of powders. An angle of slide corresponding to 33 0 corresponded to optimal flow properties.

PRECOMPRESSION STUDY Flow properties of the Liquisolid system
Flow properties of the Liquisolid systems were estimated by determining the angle of repose, Carr"s Compressibility index (CCI), and Hausner"s ratio (HR) 31 . Angle of repose was measured according to the fixed funnel and free standing cone method. A funnel with the end of the stem cut perpendicular to the axis of symmetry is secured with its tip 2 cm height, H, above a graph paper placed on a flat horizontal surface. The powders were carefully poured through the funnel until the apex of the conical pile so formed just reaches the tip of the funnel. The radius of heap was calculated and tangent of the angle of repose was given by: θ= tan -1 (H/R) Where, θ is the angle of repose, H is height of pile and R is radius of pile. The Bulk density and Tap densities were determined for the calculation of Hausner"s ratio (HR) and Carr"s Compressibility Index. (CCI).It was determined by following equation,

X100
Where, TD and BD are tapped density and bulk density respectively.

POST COMPRESSION STUDY Evaluation of liquisolid compacts Weight variation test
Twenty tablets from each formulation were selected at random and average weight was determined. Then the individual tablets were weighed and were compared with average weight 32,33 . Not more than 2 of individual weight deviate by more than percentage (Table 2), while none deviates by more than twice that percentage.

Hardness test
After preparation of matrices, primary micromeritic properties are measured like, Tablet thickness, diameter, weight and hardness. Thickness and diameter is measured by using Vernier Caliper, hardness is determined by using Monsanto hardness tester. Tablet hardness is defined as the force required breaking a tablet in a diametric compression force 34 . It is also known as tablet crushing strength. The hardness tester used in the study was Monsanto Hardness Tester, which applies the force to the tablet diametrically with the help of an in built spring. The tester was initially adjusted to zero. Powder-X Ray Diffraction (P-XRD) X-ray diffracto grams of liquisolid formulations were performed by using Philips Analytical. The cross section of samples was exposed to X-ray radiation.

FTIR Study
FTIR is an important tool to analyze the purity of the drug. FTIR spectrum shows the fundamental peaks corresponding to the chemical nature of the drug and excipients. FTIR studies were carried out in order to determine any possible interaction among drug and other excipients; it was carries out by FTIR spectrophotometer.

IN VIVO STUDIES
In-vivo studies of solid formulations Bioavailability studies of prepared solid formulations The bioavailability studies were performed for the prepared formulation containing herbal inhibitors like piperine. Female rabbit was selected as experimental model having weight 1.5 to 2.5 kg 38 . The blood serum concentration of drug was determined along with AUC, C max , and T max .

Experimental layout Study Protocol
Healthy adult albino rabbits were used for the study of pharmacokinetic parameter and were divided into 4 groups namely control, test 1, test 2 and standard. Animals were used repeatedly by keeping washout period for complete removal of drug from body. All animals were taken care of under ethical consideration as per the guidelines.

Drug administration and sampling
The animals were required to be kept on standard supplemented diet and water for one week prior to experiment and maintained on it thereafter. For study, albino rabbits were randomly assigned to four groups on body weight basis. Group 1 was serving as normal control (water), Group 2 was serving as positive control (standard drug), group 3 and 4 was treated with the liquisolid formulation and experiment was repeated for study by keeping washout period between of 8 days. The steps involved in drug administration and sampling as, shown in Figure 3.

Figure 3: Process flow of bioavailability study by taking rabbit as model Procedure for animal experimental work
The parameters were selected for the experimental work: The sample for dose was prepared with gum acacia suspension for required animal dose. Prepared solid formulation of physical mixture was administered as a single oral dose to rabbit through oral feeding needle and 2 ml of water was again given over the dose. The blood sample of rabbit was collected via ear marginal vein puncture, for that 1ml insulin syringe was used. 1 ml blood sample was collected while in each withdrawal. 3. The volume of serum sample was further diluted up to 1 ml with optimized mobile phase i.e. methanol: water (80:20 v/v). 4. Precipitation of proteins was separated by again centrifugation with 5000 rpm for 15 min. The obtained supernatant was separated with the help of micropipette. 5. The clear supernatant was again filtered with 0.42 micron Whatmann syringe filter and finally used the HPLC analysis using DAD detector.

STABILITY STUDY
Stability testing of drug products begins as a part of drug discovery and ends with the demise of the compound or commercial product. FDA and ICH specifies the guidelines for stability testing of new drug products, as a technical requirement for the registration of pharmaceuticals for human use. The formulation were wrapped in aluminum foil, and then placed in umber colored bottle 39 .

CONCLUSION
Liquisolid technique can be optimized for the production of immediate release of drug. Simplicity, low cost and capability of industrial production are some of the advantages of this technique. The complex of drug and beta cyclodextrin was successfully prepared by kneading method. Complex was taken which shows synergetic effect and enhances solubility drug. The results showed that maximum drug can be incorporated with dissolution enhancement compared with conventional formulation. Hence, this liquisolid technique with two way approach of solubility and bioavailability enhancement may found as key aspect in oral formulations. Liquisolid technique can successfully be employed to enhance the solubility and dissolution properties.